Your browser doesn't support javascript.
loading
Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma.
Naghavian, Reza; Faigle, Wolfgang; Oldrati, Pietro; Wang, Jian; Toussaint, Nora C; Qiu, Yuhan; Medici, Gioele; Wacker, Marcel; Freudenmann, Lena K; Bonté, Pierre-Emmanuel; Weller, Michael; Regli, Luca; Amigorena, Sebastian; Rammensee, Hans-Georg; Walz, Juliane S; Brugger, Silvio D; Mohme, Malte; Zhao, Yingdong; Sospedra, Mireia; Neidert, Marian C; Martin, Roland.
Affiliation
  • Naghavian R; Neuroimmunology and MS Research Section (NIMS), Neurology Clinic, University of Zurich, University Hospital Zurich, Zurich, Switzerland.
  • Faigle W; Cellerys AG, Schlieren, Switzerland.
  • Oldrati P; Neuroimmunology and MS Research Section (NIMS), Neurology Clinic, University of Zurich, University Hospital Zurich, Zurich, Switzerland.
  • Wang J; Cellerys AG, Schlieren, Switzerland.
  • Toussaint NC; Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France.
  • Qiu Y; Neuroimmunology and MS Research Section (NIMS), Neurology Clinic, University of Zurich, University Hospital Zurich, Zurich, Switzerland.
  • Medici G; Neuroimmunology and MS Research Section (NIMS), Neurology Clinic, University of Zurich, University Hospital Zurich, Zurich, Switzerland.
  • Wacker M; School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
  • Freudenmann LK; NEXUS Personalized Health Technologies, ETH Zurich, Schlieren, Switzerland.
  • Bonté PE; Swiss Institute of Bioinformatics, Zurich, Switzerland.
  • Weller M; Neuroimmunology and MS Research Section (NIMS), Neurology Clinic, University of Zurich, University Hospital Zurich, Zurich, Switzerland.
  • Regli L; Clinical Neuroscience Center, Department of Neurosurgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Amigorena S; Department of Peptide-based Immunotherapy, University of Tübingen, University Hospital Tübingen, Tübingen, Germany.
  • Rammensee HG; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Walz JS; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.
  • Brugger SD; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.
  • Mohme M; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Zhao Y; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.
  • Sospedra M; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.
  • Neidert MC; Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France.
  • Martin R; Laboratory of Molecular Neuro-Oncology, Department of Neurology and Clinical Neuroscience, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Nature ; 617(7962): 807-817, 2023 05.
Article in En | MEDLINE | ID: mdl-37198490
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Peptide Fragments / Bacteria / Bacterial Proteins / Lymphocytes, Tumor-Infiltrating / Glioblastoma / Antigens, Neoplasm Type of study: Prognostic_studies Limits: Humans Language: En Journal: Nature Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Peptide Fragments / Bacteria / Bacterial Proteins / Lymphocytes, Tumor-Infiltrating / Glioblastoma / Antigens, Neoplasm Type of study: Prognostic_studies Limits: Humans Language: En Journal: Nature Year: 2023 Document type: Article